Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Musculoskeletal | Rheumatology

Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.

First 1 2 3 Last

California

The Regents of the University of California
Los Angeles California 90055

A Phase 3 clinical study for patients with Acromegaly

Cedars-Sinai Medical Center
Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Maryland

Johns Hopkins University School of Medicine
Baltimore Maryland 21287

A Phase 3 clinical study for patients with Acromegaly

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Massachusetts General Hospital
Boston Massachusetts 02114

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

Michigan

University of Michigan Comprehensive Cancer Center SC-2
Ann Arbor Michigan 48109-0944

A Phase 4 clinical study for patients using Pasireotide

New Jersey

Ipsen
Basking Ridge New Jersey 07920

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

Pennsylvania

Allegheny Endocrinology Associates
Pittsburgh Pennsylvania 15212

A Phase 3 clinical study for patients with Acromegaly

Texas

University of Texas Southwest Medical Center
Dallas Texas 75390

A Phase 3 clinical study for patients with Acromegaly

Washington

Swedish Medical Center Neuroscience Institute
Seattle Washington 98122

A Phase 3 clinical study for patients with Acromegaly

Argentina

Novartis Investigative Site
Buenos Aires

A Phase 3 clinical study for patients with Acromegaly

Belgium

Novartis Investigative site
Bruxelles

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Bruxelles 1200

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Edegem 2650

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative site
Leuven

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Leuven 3000

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Liege 4000

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative site
Wilrijk

A Phase 3 clinical study for patients with Acromegaly

Brazil

Novartis Investigative Site
Botucatu

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Campinas

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Fortaleza

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Joinville

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative site
Rio de Janeiro

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
São Luiz

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative site
São Paulo

A Phase 3 clinical study for patients with Acromegaly

Canada

Novartis Investigative Site
Edmondton

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Halifax

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Montreal

A Phase 3 clinical study for patients with Acromegaly

CHUM - Notre-Dame Hospital
Montreal Quebec H2L 4M1

Patients are needed to participate in a clinical research study evaluating Alesse for the treatment of Acromegaly

Novartis Investigative Site
Sherbrooke

A Phase 3 clinical study for patients with Acromegaly

Colombia

Novartis Investigative Site
Bogota

A Phase 3 clinical study for patients with Acromegaly

France

Novartis Investigative Site
Bron

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Dijon

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Kremlin Bicetre

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Lille

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Marseille

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Nantes

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Paris

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Pessac

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Rennes

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Toulouse

A Phase 3 clinical study for patients with Acromegaly

Germany

Campus Charité Mitte
Berlin

A clinical research study of Active oral octreotide study drug therapy for the treatment of Acromegaly

Novartis Investigative Site
Berlin

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Erlangen

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Essen

A Phase 3 clinical study for patients with Acromegaly

ENDOC Center for Endocrine Tumors
Hamburg 20357

A clinical research study of Active oral octreotide study drug therapy for the treatment of Acromegaly

ENDOC
Hamburg 20357

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Novartis Investigative Site
Hamburg

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
Leipzig

A Phase 3 clinical study for patients with Acromegaly

Novartis Investigative Site
München

A Phase 3 clinical study for patients with Acromegaly

First 1 2 3 Last